glp 1 kidney Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic disease through dampening the receptor for advanced glycation end products–induced inflammation GLP1 Receptor Agonists vs SGLT2-I
Description
Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum)
10.2337/db23-127-OR 77.Wilson JM, Nikooienejad A, Robins DA, et al
Efinopegdutide Emerging data on novel agents continue to expand the evidence base
By promoting feelings of fullness and slowing gastric emptying, they reduce calorie consumption, making it simpler for people to sustain a calorie deficit and lose weight in a long-term way
Med Sci Monit
